Trump signs order to expedite medical psychedelic drug treatment, research
President Trump signed an executive order Saturday to fast-track access to medical psychedelic drug research and treatment.
Trump signs order to speed research on psychedelics for mental health
April 18 (UPI) -- President Donald Trump signed an executive order Saturday to accelerate research for some psychedelic drugs to treat mental health disorders.
Joe Rogan's text to Trump spurred psychedelic drug policy change
A text from Joe Rogan to Donald Trump set off a rapid White House push to fast-track psychedelic drug policy. Trump signed an executive order for research into drugs like ibogaine and LSD.
Trump signs order to accelerate access to psychedelic drug treatments
Health Secretary ​Robert F. Kennedy Jr. has championed the idea of using drugs such as ibogaine as an alternative treatment for mental health conditions such as depression.
Trump signs order to accelerate access to psychedelic drug treatments
Health Secretary ​Robert F. Kennedy Jr. has championed the idea of using drugs such as ibogaine as an alternative treatment for mental health conditions such as depression.
Trump fast-tracks psychedelic drug treatments for mental illness
President Donald Trump on Saturday directed the U.S. Food and Drug Administration to accelerate review of certain psychedelic substances like ibogaine on a federal basis – in his...
Trump Signs Executive Order to Expedite Testing of Psychedelics Use to Combat PTSD
Following a text from Joe Rogan, Donald Trump signed an executive order to hasten the research of psychedelics use to combat PTSD.
Trump Signs Executive Order to Expedite Testing of Psychedelics Use to Combat PTSD
Following a text from Joe Rogan, Donald Trump signed an executive order to hasten the research of psychedelics use to combat PTSD.
Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."
Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."
last updated on 19 Apr 05:46